Trial Profile
A Pilot Study to Evaluate Short Term Neoadjuvant Sonidegib Followed by Surgery or Imiquimod in the Management of Basal Cell Carcinomas in Cosmetically Challenging Locations
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 19 Feb 2024
Price :
$35
*
At a glance
- Drugs Sonidegib (Primary) ; Imiquimod
- Indications Basal cell cancer
- Focus Therapeutic Use
- Acronyms SONIB
- 12 Feb 2024 Planned number of patients changed from 10 to 20.
- 12 Feb 2024 Planned End Date changed from 1 Dec 2023 to 1 Jun 2024.
- 12 Feb 2024 Planned primary completion date changed from 1 Dec 2023 to 1 Jun 2024.